Nutrastar International Inc. Announces First Quarter 2014 Results - KTEN.com - No One Gets You Closer

Nutrastar International Inc. Announces First Quarter 2014 Results

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Nutrastar International Inc.

Revenue of $6.87 Million; Gross Margin at 76.3%; Company Maintains Forecasts for 2014 Revenue of Between $47 Million and $50 Million

HARBIN, China, May 13, 2014 /PRNewswire/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages, and organic and specialty foods, today announced its results for the three months ended March 31, 2014.

Financial Highlights

  • Net revenue was $6.87 million, a decrease of 0.54 million from $7.41 million from comparable 2013 period.
  • Gross profit was $5.24 million, representing a gross margin of 76.3%.
  • Net income was $3.23 million, representing a net margin of 47.1%.
  • Basic and diluted EPS were $0.19 and $0.18, respectively, with 16.66 million basic shares and 17.65 million diluted shares outstanding.

Management Commentary

Ms. Lianyun Han, CEO of Nutrastar, commented, "Increased demand for our 210ml and 310ml beverage offerings coupled with a decline in demand for 160ml beverage product forced us to realign the beverage product lines. This led to a temporary delay in finished goods deliveries to our beverage customers in Q1 2014 and a slightly higher inventory balance at March 31, 2014. In addition, it required us to reallocate a portion of finished Cordyceps goods towards production of beverages for the 210ml and the 310ml product lines. This resulted in a decrease in total sales of approximately $0.54 million or 7.3% in the first quarter of 2014. Consequently, and despite strong demand, our core product Cordyceps saw flat year-over-year sales of $6.06 million. Organic specialty foods, our third consumer product category, was unaffected by the product realignment and experienced sales growth of 5.3%. We do not expect further delays in the current and forthcoming quarters, assuming unforeseeable events do not adversely affect future production and delivery schedule. Going forward, we expect that demand increases for the 210ml and 310ml beverage product lines will outpace any demand shortfall from 160ml beverages."

Ms. Han continued, "In the three months ended March 31, 2014, gross profit and net income, as a percentage of revenue, improved to 76.3% and 47.1%, respectively, from 76.1% and 46.0% in the same quarter of 2013. These improvements were mainly attributable to lower sales volume of our beverages, which have a relatively higher production cost than our other products."

"We are the single largest provider of commercially cultivated Cordyceps Militaris and over the past few years, we have used that as leverage to expand into other synergistic premium consumer product categories. This strategy has resulted in the successful diversification of Nutrastar - both by product and revenue. We continue to capitalize on rising demand stemming from China's young, increasing affluent, and aging populations, and are now working on expanding our reach - both domestically in China and internationally via new products such as our in-development Cordyceps capsules and tablets which will cater to health conscious, on-the-go customers. These new products, a continuation in our marketing measures, and an expansion in our geographical reach will allow us to grow and achieve key milestones set forth in our long-term growth plan. Working with members of our board of directors, we are beginning to identify strong and seasoned talent with international nutraceutical experience to supplement the Nutrastar team, particularly as we prepare for international expansion. We will keep the public and shareholders apprised of our development progress with these initiatives and in all other areas of our business," added Ms. Han.

Nutrastar encourages any interested party to reach out directly for more information on the Company and its innovative, premium consumer product portfolio.

Outlook for the Year Ending December 31, 2014

Based on management's current expectations, full year 2014 revenue should fall in the range of $47 million to $50 million, representing an approximate 8% to 15% year-over-year top line growth.

Request for Call with Management

Investors are invited to request a call with Nutrastar's management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.

For more information regarding Nutrastar's financial performance during the three months ended March 31, 2014, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission on or about May 13, 2014.

About Nutrastar International Inc.

Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages, as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 330 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com

Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts

 Safe Harbor Statement

This news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors.  You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Howard Gostfrand
American Capital Ventures
Tel:  +1-305-918-7000
Email: info@amcapventures.com

 

NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(Unaudited)

(AMOUNTS EXPRESSED IN US DOLLARS)




For the Three Months Ended


March 31,


2014


2013







REVENUE

$

6,866,681


$

7,411,136







Cost of goods sold


(1,628,254)



(1,772,288)







GROSS PROFIT


5,238,427



5,638,848







Selling expenses


(247,063)



(430,463)

General and administrative expenses


(673,015)



(592,515)







Income from operations


4,318,349



4,615,870







Other income (expenses):












   Interest income


91,858



83,741

   Foreign exchange differences


(18,089)



(5,187)

   Total other income


73,769



78,554







Income before income taxes


4,392,118



4,694,424







Provision for income taxes


(1,158,544)



(1,279,740)







NET INCOME


3,233,574



3,414,684







OTHER COMPREHENSIVE INCOME:






Foreign currency translation adjustments


(1,052,829)



239,747







COMPREHENSIVE INCOME

$

2,180,745


$

3,654,431







Earnings per share






   Basic

$

0.19


$

0.21

   Diluted

$

0.18


$

0.20







Weighted average number of shares outstanding






   Basic


16,657,418



15,863,826

   Diluted


17,645,322



16,995,928

 

NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(AMOUNTS EXPRESSED IN US DOLLARS)



March 31,
2014


December 31, 2013


(Unaudited)



ASSETS  






CURRENT ASSETS






 Cash and cash equivalents

$

103,134,535


$

102,599,186

 Accounts receivable


96,526



56,922

 Inventories


1,726,646



691,847

 Prepayments and other receivables


764,451



1,300,012

   Total current assets


105,722,158



104,647,967

 OTHER ASSETS






 Intangible assets, net


975,852



1,107,737

 Property, plant and equipment, net


15,093,577



15,481,249







   Total assets

$

121,791,587


$

121,236,953







LIABILITIES AND STOCKHOLDERS' EQUITY 






 CURRENT LIABILITIES






 Other payables and accruals

$

1,055,400


$

1,167,957

 Taxes payable


1,158,360



2,879,172

 Due to a related party


412,689



265,223

 Preferred stock dividend payable


563,093



738,903

   Total current liabilities


3,189,542



5,051,255

   Total liabilities


3,189,542



5,051,255

 COMMITMENTS AND CONTINGENCIES






 STOCKHOLDERS' EQUITY






 Preferred Stock, $0.001 par value, 1,000,000 shares authorized, 77,776 shares and 
       110,066 shares issued and outstanding at March 31, 2014 and December 31,
       2013, respectively; aggregate liquidation preference amount: $2,177,728 and
       $ 3,081,848, plus accrued but unpaid dividend of $563,093 and $738,903, at
       March 31, 2014 and December 31, 2013, respectively


1,773,772



2,510,183







 Common stock, $0.001 par value, 190,000,000 shares authorized, 16,858,541 shares 
       issued and 16,814,986 shares outstanding at March 31, 2014; 16,421,161 shares 
       issued and 16,377,606 shares outstanding at December 31, 2013


16,859



16,422







 Additional paid-in capital


20,952,803



19,934,551

 Statutory reserves


4,989,054



4,983,935

 Treasury stock, at cost, 43,555 shares
       as of March 31, 2014 and December 31,2013


(78,767)



(78,767)

 Retained earnings


83,424,656



80,242,877

 Accumulated other comprehensive income


7,523,668



8,576,497

   Total stockholders' equity


118,602,045



116,185,698







   Total liabilities and stockholders' equity

$

121,791,587


$

121,236,953

 

NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(AMOUNTS EXPRESSED IN US DOLLARS)




For the Three Months Ended



March 31,



2014



2013

CASH FLOWS FROM OPERATING ACTIVITIES:






Net income

$

3,233,574


$

3,414,684

Adjustments to reconcile net income to cash provided by operating activities:






   Consultant restricted stock expense


14,558



-

   Depreciation and amortization


372,777



362,996

   Share-based compensation expense


45,234



54,006

(Increase) decrease in assets:






         Accounts receivable


(40,338)



(584)

         Inventories


(1,046,809)



(754,380)

         Prepayments and other receivables


526,815



445,232

Increase (decrease) in liabilities:






         Other payables and accruals


(75,594)



83,749

         Advance from related party


139,989



-

         Taxes payable


(1,704,426)



(1,452,440)

     Net cash provided by operating activities


1,465,780



2,153,263







Foreign currency translation adjustment


(930,431)



262,317







INCREASE IN CASH AND CASH EQUIVALENTS


535,349



2,415,580

CASH AND CASH EQUIVALENTS, at the beginning of the period


102,599,186



75,526,533







CASH AND CASH EQUIVALENTS, at the end of the period

$

103,134,535


$

77,942,113







NON-CASH TRANSACTIONS






Preferred stock and dividend converted into common stock

$

958,897


$

-

Preferred stock dividend payable


46,676



55,392

Share-based payment to officers and directors under equity incentive plan


45,234



54,006

Share-based payment – IR warrants


14,558



-

SUPPLEMENTAL DISCLOSURE INFORMATION






Income taxes paid

$

2, 355,699


$

2,168,693

©2012 PR Newswire. All Rights Reserved.